An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 01/15/2025 12:22 AM
Question 20041053
Inquiry Details
References:
#1: CS Manual, Part II, 465. Vers 1.0, Jan. 1, 2004
#2: 2004 SEER Manual, C-484
Question:
CS Site Specific Factor 6--Breast: Can we interpret the in situ component as "minimal" when the pathology report states "1.1 cm infiltrating duct carcinoma and no extensive intraductal component"?
Discussion:
Answer:
This answer was provided in the context of CSv1 coding guidelines. The response may not be used after your registry database has been converted to CSv2.
Yes. Based on the information provided above, the in situ component is "mininmal" for the purpose of coding Breast CS Site Specific Factor 6. The phrase "no extensive intraductal component" suggests that there is some intraductal carcinoma present.
Cancer Site Category:
Breast
Data Item Category:
N/A
Other Category:
N/A
Year:
2004
